Adiyaman University Repository

Is It Justifiable to Move the Grade-1 Ki67 Index Cut-Off from 3% to 5% for Pancreatic Neuroendocrine Tumors as Has Been Proposed? The Cases That Fall to 3-5% Category Have Clinicopathologic Characteristics Closer to Those > 5%

Files in this item

This item appears in the following Collection(s)

Search DSpace


Advanced Search

Browse

My Account